Sickle Cell Disease for Health Professionals

A new smartphone app could be a boon for adolescents, young adults When the Food and Drug Administration (FDA) approved the drug hydroxyurea to help reduce the excruciating pain suffered by people with sickle cell disease, the health care community was hopeful. The year was 1998, and the prospect of a drug that could offer significant relief from the devastating effects of a disease that had no cure seemed promising. Only thing, patients would have to take the drug as prescribed to fully reap its benefits. And in the decades since its approval, that has proven to be more of a challenge than...